Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sickle ß0-Thalassemia”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Study completedNCT01179217
What this trial is testing

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Who this might be right for
Sickle Cell AnemiaSickle ß0-Thalassemia
Emmaus Medical, Inc. 230
Testing effectiveness (Phase 2)Ended earlyNCT00586209
What this trial is testing

L-Glutamine Therapy for Sickle Cell Anemia

Who this might be right for
Sickle Cell AnemiaThalassemia
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT00125788
What this trial is testing

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

Who this might be right for
Sickle Cell AnemiaThalassemia
Emmaus Medical, Inc. 70

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation